Strange: Bullish CNST Analysts Actually See -18.93% Downside
December 09, 2019 at 09:26 AM EST
Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Constellation Pharmaceuticals Inc (CNST). The average 12-month price target for CNST — averaging the work of 7 analysts — reveals an average price target of $35.43/share..